By Stewart Eisenhart, Emergo Group
Citing security vulnerabilities, the US Food and Drug Administration has extended deadlines for compliance with a key component of the agency’s Unique Device Identification (UDI) system.
Requirements for submitting labeling and data for implantable, life-supporting and life-sustaining devices to the FDA’s Global Unique Device Identification Database or GUDID, originally given a September 24 2015 deadline, must now be met by October 24, 2015.
This new deadline also applies to Class III devices whose manufacturers have filed for and obtained compliance extensions that expire between August 7 and September 24 2015.
GUDID was taken offline August 7 after the discovery of a “security vulnerability,” the nature of which was not disclosed in the FDA notice.
Stewart Eisenhart covers medical device regulatory affairs for Emergo Group.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
